Interim Chief Medical Officer
Real Team.
Real Purpose.
Our StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur Story
Our StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur StoryOur Story
Our Story
Our mission is to discover, develop, and commercialize medicines that improve the lives of patients by combining the potential of high-value GPCR drug targets with the power of state-of-the-art small molecule drug discovery technologies. Septerna’s Native Complex™ Platform is the engine that will make this happen, moving ideas for disease-modifying therapies from possibility to reality.
Septerna has assembled a team that thrives on innovation, combining pioneering GPCR scientists with experienced drug hunters. Our founders have made seminal discoveries that reveal the inner workings of GPCRs and how they control physiology. Our scientists have built upon these unique insights to develop our industrial-scale Native Complex™ Platform.
We are focusing the Native Complex™ Platform on tackling previously difficult-to-drug GPCR targets, and our small molecule drug discovery efforts have rapidly advanced, resulting in a pipeline of innovative programs. With an unprecedented level of productivity, we are setting the stage for a new future for GPCR-targeted medicines.
Our TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur Team
Our TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur TeamOur Team
Our Team
Alan Ezekowitz, M.D., D.Phil.
Alex Kunzle
Protein Sciences
Ali Masoudi, Ph.D.
Protein Sciences
Amer M. Mirza, Ph.D.
Vice President, Disease Biology and Translational Sciences
Ariel Wein, Ph.D.
Protein Sciences
Chia-Hung Tai
Discovery Biology
Chris Heise, Ph.D.
Vice President, Discovery Biology
Daniel Long, D.Phil.
Senior Vice President, Drug Discovery
Dean P. Staus, Ph.D.
Protein Sciences
Dodzie Sogah, Ph.D.
Interim Chief Operating Officer
Elyas Kefela
Operations
Evan Green, Ph.D.
Protein Sciences
George Xu, Ph.D.
Director, Corporate Strategy & Portfolio Development
Jeffrey Finer, M.D., Ph.D.
Interim President & Chief Executive Officer
Jialu Wang, Ph.D.
Protein Sciences
Kathryn Luderman, Ph.D.
Discovery Biology
Kara Halvorsen
Interim Head, Human Resources
Kris Dalmacio
Operations
Matthew Volgraf, Ph.D.
Medicinal Chemistry
Michael Broeker
Operations
Richard Hansen, Ph.D.
Vice President, Technology
Richard van Rijn, Ph.D.
Disease Biology
Ryan Strachan, Ph.D.
Discovery Biology
Uwe Klein, Ph.D.
Senior Vice President, Biological Sciences
Victoria Wu, Ph.D.
Disease Biology
Our Teams
Robert Lefkowitz, M.D.
Duke University, HHMI
Arthur Christopoulos, Ph.D.
Monash University
Patrick Sexton, PhD, DSc
Monash University
Jeffrey Finer, M.D., Ph.D.
Director, Interim CEO
Septerna, Third Rock Ventures
Investors
Join Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our Team
Join Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our TeamJoin Our Team
Join our growing team of experts